This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Friedrich-Schiller-Universitat Jena, Université D'angers, University of Innsbruck. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019
Title: Innovations by Veronika Sophie Temml: Focus on Tocotrienol Derivatives
Introduction
Veronika Sophie Temml is a distinguished inventor based in Innsbruck, Austria. She has made significant contributions to the field of pharmaceutical compositions, particularly with her work on tocotrienol derivatives. Her passion for innovation has led her to develop methods that address 5-lipoxygenase related diseases.
Latest Patents
Temml holds a patent for her invention titled "Tocotrienol derivatives, pharmaceutical composition and method of use in 5-lipoxygenase related diseases." The patent focuses on compounds of formula (III) and formula (IV), showcasing her expertise in pharmacology and her commitment to improving health outcomes.
Career Highlights
Throughout her career, Veronika Sophie Temml has been associated with prominent academic institutions, including the Université d'Angers and the Universität Innsbruck. These affiliations have provided her with a robust platform to conduct research and drive innovations in her field.
Collaborations
In her journey as an inventor, Temml has collaborated with esteemed colleagues such as Pascal Richomme and Jean-Jacques Helesbeux. These partnerships have enriched her work and contributed to advancing research in pharmaceutical sciences.
Conclusion
Veronika Sophie Temml exemplifies the spirit of innovation through her impactful patent and significant academic collaborations. Her contributions to pharmaceutical compositions not only reflect her expertise but also highlight the importance of dedication to research. As the landscape of health-related inventions continues to evolve, her work stands as a testament to the potential of innovative solutions in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile